| answer text |
<p>The Clinical Commissioning Group Improvement and Assessment Framework (CCG IAF)
contains two recognised evidence-based measures of whether patients with diabetes
are being supported to successfully manage their condition. These are the achievement
of the National Institute for Health and Care Excellence (NICE) treatment targets,
which cover blood sugar, blood pressure and cholesterol control, and participation
in structured education programmes.</p><p> </p><p>These measures were selected to
reflect matters highlighted by the Public Accounts Committee (PAC) in January 2016
in its report on the management of adult diabetes services. The purpose of the CCG
IAF is to highlight the key areas where clinical commissioning groups (CCGs) need
to make improvements. The number of CCGs in need of improvement against these two
indicators is consistent with the findings of the PAC.</p><p> </p><p>The NHS Operational
Planning and Contracting Guidance 2017-2019 included an announcement that NHS England
intends to launch a major programme of investment in the treatment and care of people
with diabetes. As part of this, CCGs will be able to bid for additional funding of
around £40 million per year for priorities which include improvements in relation
to the achievement of the treatment targets and attendance at structured education
programmes.</p>
|
|
